NEW YORK (GenomeWeb News) – The Center for Human Genetics of Boston University and the Center for Human Genetics Inc., will stop offering testing services that are covered by patents licensed to Athena Diagnostics, Boston University said today.
 
Athena Diagnostics, a subsidiary of Thermo Fisher Scientific, focuses on offering tests for neurological diseases, such as Alzheimer’s disease and neuromuscular diseases, that it licenses from universities.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

In Nature this week: a Danish reference genome, and more.